as on February 3, 2026 at 3:16 pm IST
52 Week's Low
52 Week's High
23.50%
Downside
20.58%
Upside
as on February 3, 2026 at 3:16 pm IST
Market Cap
₹5.78 Cr
Return on Equity (ROE)
-41.33
PE Ratio (TTM)
0Return on capital employed (ROCE)
-18.71
Beta (LTM)
-0.42
P/B Ratio
1.45
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
0EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Brawn Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 5.78 | -3.51% | 0.00 | -2 | 13 | |
| NA | 224.42 | 106.81% | 0.00 | -10 | 109 | |
| NA | 6,993.44 | 33.53% | 0.59 | 272 | 2,115 | |
| NA | 48.89 | 4.6% | 0.00 | 1 | 14 | |
| NA | 252.76 | 29.27% | 0.64 | 7 | 138 |
Get share price movements and forecasts by analysts on Brawn Biotech.
Source: S&P Global Market Intelligence
Search interest for Brawn Biotech Ltd Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Brawn Biotech.
Brawn Biotech Ltd’s net profit fell -300% since last year same period to ₹0.04Cr in the Q1 2023-2024. On a quarterly growth basis, Brawn Biotech Ltd has generated -117.39% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2018, Brawn Biotech Ltd has declared dividend of ₹1.00 per share on 29 May 2018 - translating a dividend yield of 12.41%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 45.99% to 46.26% in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 160.3% return, outperforming this stock by 168.4%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 11.0%
Promoter Holding Down
![]()
Promoters have decreased holdings from 53.66% to 53.39% in Dec 2025 quarter
Price Dip
![]()
In the last 7 days, Brawn Biotech stock has moved down by -7.9%
| Organisation | Brawn Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Brawn Biotech share price today stands at ₹20.21 as on at the close of the market. Brawn Biotech share today touched a day high of ₹20.21 and a low of ₹20.21.
Brawn Biotech touched a 52 week high of ₹24.37 and a 52 week low of ₹15.46. Brawn Biotech share price today i.e. is closed at ₹20.21, which is -17.07% down from its 52 week high and 30.72% up from its 52 week low.
Brawn Biotech market capitalisation is ₹5.78 Cr as on .
To buy Brawn Biotech shares, you need to follow these steps:
Brawn Biotech trading volume is 2,413.00 as on . This means that 2,413.00 shares of Brawn Biotech were bought and sold on the stock market during today's trading session.